title: Corticostriatal LTP requires combined mGluR1 and mGluR5 activation.
abstract: Metabotropic glutamate receptors (mGluRs) have been demonstrated to play a role in synaptic plasticity. It has been recently shown that mGluR1 is involved in corticostriatal long-term depression, by means of pharmacological approach and by using mGluR1-knockout mice. Here, we report that both mGluR1 and mGluR5 are involved in corticostriatal long-term potentiation (LTP). In particular, the mGluR1 antagonist LY 367385, as well as the mGluR5 antagonist MPEP, reduce LTP amplitude. Moreover, blockade of both mGluR1 and mGluR5 by LY 367385 and MPEP co-administration fully suppresses LTP. Accordingly, group II and group III mGluRs antagonists fail to affect LTP induction. Interestingly, LTP amplitude is also significantly reduced in both mGluR1- and mGluR5-knockout mice. The differential function of mGluR1 and mGluR5 in corticostriatal synaptic plasticity may play a role in the modulation of the motor activity mediated by the basal ganglia, thus providing a substrate for the pharmacological treatment of motor disorders involving the striatum.
authors.affiliation: Istituto di Neurobiologia e Medicina Molecolare, CNR, Rome, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Gubellini
authors.forename: E
authors.initials: E
authors.lastname: Saulle
authors.forename: D
authors.initials: D
authors.lastname: Centonze
authors.forename: C
authors.initials: C
authors.lastname: Costa
authors.forename: D
authors.initials: D
authors.lastname: Tropepi
authors.forename: G
authors.initials: G
authors.lastname: Bernardi
authors.forename: F
authors.initials: F
authors.lastname: Conquet
authors.forename: P
authors.initials: P
authors.lastname: Calabresi
mesh_terms: D000818:Animals; D001565:Benzoates; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology; D066298:In Vitro Techniques; D017774:Long-Term Potentiation; D008297:Male; D008564:Membrane Potentials; D051379:Mice; D018345:Mice, Knockout; D019579:Neocortex / Q000187:drug effects* / Q000502:physiology; D017072:Neostriatum / Q000187:drug effects* / Q000502:physiology; D018408:Patch-Clamp Techniques; D011725:Pyridines / Q000494:pharmacology; D064529:Receptor, Metabotropic Glutamate 5; D018094:Receptors, Metabotropic Glutamate / Q000187:drug effects* / Q000502:physiology
chemical_list: D001565:Benzoates; D018691:Excitatory Amino Acid Antagonists; C578936:Grm5 protein, mouse; D011725:Pyridines; D064529:Receptor, Metabotropic Glutamate 5; D018094:Receptors, Metabotropic Glutamate; C104077:metabotropic glutamate receptor type 1; C079694:alpha-methyl-4-carboxyphenylglycine; C121465:6-methyl-2-(phenylethynyl)pyridine; D005998:Glycine